tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB

Matinas BioPharma (MTNB) Cash flow

1,434 Followers

Matinas BioPharma Cash Flow

MTNB's free cash flow for Q3 2023 was $-4.43M. For the 2023 fiscal year, MTNB's free cash flow was decreased by $-4.57M and operating cash flow was $-4.42M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -15.00M$ -19.16M$ -15.22M$ -17.37M$ -14.09M$ -10.32M
Investing Cash Flow
$ 10.24M$ 4.88M$ 16.77M$ -40.67M$ -6.01M$ -535.92K
Financing Cash Flow
$ -10.64K$ 79.00K$ 6.96M$ 48.05M$ 29.85M$ 15.87M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 28.34M$ 7.08M$ 21.28M$ 12.77M$ 22.76M$ 13.01M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 5.58M$ 46.70M$ 30.10M$ 16.30M
Issuance Of Debt
$ -10.20K$ -20.00K$ -30.00K---
Repayment Of Debt
$ -10.20K$ -20.00K$ -30.00K$ -54.67K$ -281.56K$ -429.26K
Free Cash Flow
$ -15.26M$ -20.05M$ -15.48M$ -17.37M$ -14.50M$ -10.86M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Matinas BioPharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis